IBX — Imagion Biosystems Share News
0.000.00%
Last trade - 00:00- AU$2.70m
- AU$4.83m
- AU$0.03m
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt
Australia's Imagion Biosystems surges on US regulatory win for imaging agent
Brief: Imagion Biosystems Receives A$300,000 Additional Funding Under Mercer Street Agreement
Brief: Imagion Biosystems Files IND To FDA For Phase 2 Trial Of Magsense Her2 Targeted Imaging Agent
Brief: Imagion Biosystems Says A$3.5M Capital Raising
Brief: Imagion Biosystems Seeks Trading Halt
Australia's Imagion Biosystems hits 8-month low on discounted placement
Brief: Imagion Biosystems Announces Successful Placement Of A$3 Mln
Brief: Imagion Biosystems Seeks Trading Halt
Brief: Imagion Biosystems Says FY Revenue Up 68.7% To A$5.2 Million
Brief: Imagion Biosystems Lowers Operating Expenses Through Further Staff Reductions
Brief: Imagion Biosystems Announces Resignation Of CEO Isaac Bright
Brief: Imagion Biosystems Says FY Net Loss Attributable A$7.6 Mln
Brief: Imagion Biosystems Says Management Expects R&D Costs To Increase During Remainder Of 2023
Brief: Imagion Biosystems Receives A$1 Million From Mercer Street Global Opportunity Fund
Australia's Imagion Biosystems rises on MOU for cancer detection device